A random-effects model also indicated no significant difference in the prevalence of IgA or IgM NMDAR antibodies between all dementia cases (typical and atypical) and healthy individuals, [OR = 1.93 (95% CI: 0.67 to 5.60), p = 0.227) or between typical dementia and healthy individuals [OR = 1.30 (95% CI: 0.58 to 2.90), p = 0.526] (see Table 3). The gene discussed is CD79A; the disease is dementia.